ViaCyte's Convertible Note - II Round

ViaCyte raised a round of funding on September 25, 2018. Investors include W. L. Gore & Associates.

ViaCyte, a private company that has emerged as a provider in the field of regenerative medicine, is focused on developing a therapy for the treatment of diabetes. The Company's lead product is based o…

Articles about ViaCyte's Convertible Note - II Round: